Moleac.com
  • Home
  • About Us
    • Vision, Values & Mission
    • Milestones
    • Leadership
      • Management Team & Advisors
      • Board of Directors
      • Scientific Advisors & Collaborators
    • Our People, Our Company
    • Responsibility
  • R & D
    • Pipeline
    • Our Strategic Approach
    • Research & Development
    • Publications
  • Products
    • NeuroAiD™II
  • Partners
    • Our Commercial Partners
    • Commercial Partnering Opportunities
    • Research Opportunities
  • News
  • Library
  • Contact Us
  • Career
Select Page
Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report

Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report

Sep 25, 2024 | News

Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report ALZHEIMER’S DISEASE STUDY HIGHLIGHTS – Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force by Angioni,...
Creating a Greener Workplace: Moleac’s Commitment to Sustainability

Creating a Greener Workplace: Moleac’s Commitment to Sustainability

Sep 24, 2024 | News

Creating a Greener Workplace: Moleac’s Commitment to Sustainability At Moleac, we are dedicated to sustainability, and we are excited to share the steps we are taking to create an eco-friendly workplace! From cutting back on air conditioning to ensuring monitors are...
Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives

Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives

Sep 21, 2024 | News

Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives Today is World Alzheimer’s Day!Every year on September 21st, World Alzheimer’s Day offers a meaningful opportunity to raise awareness about Alzheimer’s disease and to...
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories

Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories

Sep 11, 2024 | News

Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories ANNOUNCEMENT – INDONESIAWe are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML). “To whom it may concern,PML would like...
World Alzheimer’s Day: Practical Tips to Support Patients and Caregivers

World Alzheimer’s Day: Practical Tips to Support Patients and Caregivers

Sep 9, 2024 | News

World Alzheimer’s Day: Practical Tips to Support Patients and Caregivers World Alzheimer’s Day is just around the corner! At Moleac, we’re committed to raising awareness about Alzheimer’s disease and fostering a deeper understanding of its impact on daily life....
« Older Entries
Next Entries »

Categories

  • Alzheimer News
  • News
  • Stroke News
  • TBI News

Recent Posts

  • Join Moleac at ESOC 2025 in Helsinki: Advancing Stroke Care Together
  • Strengthening Neurological Care: Insights from Moleac’s Scientific Conference in Bali
  • Advancing Neurological Care: Highlights from Moleac’s Scientific Conference in Montenegro
  • Celebrating Earth Day: Moleac Supports Seacology’s Conservation Efforts in Malaysia
  • Post-Stroke Dementia in Southeast Asia: New Review Highlights Urgent Research and Care Gaps

Quick links

Home
About Us
Contact
Privacy Policy
Terms & Conditions

Find us

Moleac Pte Ltd

Contact

  • Helios #09-08, 11 Biopolis Way, Singapore 138667
  • +65 62113710
  • [email protected]

Connect

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2003-2025. All Rights Reserved. NeuroAiD by Moleac Pte Ltd, Helios #09-08, 11 Biopolis Way, Singapore 138667

loading

Please wait while you are redirected to the right page...